Talampanel in Treating Patients With Recurrent High-Grade Glioma
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as talampanel use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well talampanel works in treating patients with
recurrent, progressive high-grade glioma.
Phase:
Phase 2
Details
Lead Sponsor:
National Institutes of Health Clinical Center (CC)